Loading viewer...
investor_presentation
Format: PDF investor_presentation
Lonza Group Ltd announced the acquisition of Capsugel to accelerate growth across the healthcare continuum. The deal, presented in December 2016, combines Lonza's pharmaceutical and biotech capabilities with Capsugel's capsule and dosage form technologies. This strategic acquisition strengthens Lonza's position as an integrated supplier across pharmaceutical manufacturing and life sciences sectors.
investor_presentation
34 Pages
investor_presentation
26 Pages
Cadiz